OREANDA-NEWS. Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present innovative uses of ethylene vinyl acetate (EVA) at the 2015 CPhI Worldwide conference October 13-15 in Madrid, Spain. Celanese material experts will exhibit the innovative controlled release pharmaceutical copolymer, VitalDose® EVA, at booth number 7A54SSP in Hall 7.

“EVA has been used for years in drug delivery systems,” said Dr. Donald Loveday, Celanese strategic marketing manager. “VitalDose EVA is an inert thermoplastic that is expanding design possibilities with its customizable drug release properties. This controlled release excipient is developed for a wide variety of pharmaceutical products with varying routes of administration, including intraoral, intravaginal, ocular, subcutaneous and transdermal.”

Celanese material experts will discuss these topics and more at a Pharma Insight Briefing & Reception:

  • Why use EVA in Drug Development and Controlled Release
  • Current Application Areas and Uses of EVA
  • Next Generation Innovations for EVA
  • Celanese Support of Conventional and Novel Uses of EVA

Celanese Pharma Insight Briefing & Reception

Date/Time:  

Tuesday, October 13, 2015 at 16:00
Location:   Pharma Forum, 2015 CPhI Worldwide
Presenters:   Dr. Donald Loveday, Strategic Marketing Manager and Dr. Christian Schneider, Technical Service and Product Developer
Topic:  

Innovative Uses of Ethylene Vinyl Acetate (EVA) in Drug Delivery Systems: Novel and Conventional